Sorafenib

[ customers have already purchased this product.]

Share |

Product name : Sorafenib

CAS : 284461-73-0

Molecular formula : C₂₁H₁₆ClF₃N₄O₃
Product description :
Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar), is a drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer (hepatocellular carcinoma).Sorafenib was approved by the U.S. Food and Drug Administration (FDA) in December 2005,and received European Commission marketing authorization in July 2006,both for use in the treatment of advanced renal cancer.

Please feel free to for: Sorafenib Quotation ( Sorafenib suppliers),COA (Certificate of Analysis), New Sales Promotion,New Products,And any other assistance.

<< HDMP-28HDMP-28Tryptamines >>

Send to this supplier

After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@Greenstoneswiss.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6515 7632
4. Send enquiry online: